Medicare Enrolled

Dr. Lucy Won, D.O.

Psychiatry · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4221 WILSHIRE BLVD STE 311, Los Angeles, CA 90010
3239175155
In practice since 2014 (12 years)
NPI: 1497172613 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Won from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Won? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Won

Dr. Lucy Won is a psychiatry specialist in Los Angeles, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Won performed 600 Medicare services across 223 unique beneficiaries.

Between the years covered by Open Payments, Dr. Won received a total of $8,812 from 27 pharmaceutical and/or device companies across 500 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Won is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 24% volume in CA $8,812 industry payments

Medicare Practice Summary

Medicare Utilization ↗
600
Medicare services
Top 24% in CA for psychiatry
223
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~50 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
320 $80 $235
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
134 $46 $86
Nursing facility visit, moderate complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes.
69 $91 $151
Initial nursing facility care, high complexity
An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes.
30 $152 $343
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
26 $156 $350
Initial nursing facility care, moderate complexity
Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes.
21 $105 $286
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,812
Total received (2018-2024)
Avg $1,259/year across 7 years
Top 6% in CA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
500
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,812 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,017
2023
$388
2022
$959
2021
$1,292
2020
$1,044
2019
$2,145
2018
$967

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$510
Janssen Pharmaceuticals, Inc
$496
Alkermes, Inc.
$356
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$226
Otsuka America Pharmaceutical, Inc.
$182
E.R. Squibb & Sons, L.L.C.
$115
ACADIA Pharmaceuticals Inc
$91
Teva Pharmaceuticals USA, Inc.
$40
Top 3 companies account for 67.6% of 2024 payments
All-time payments by company (2018-2024) ›
Alkermes, Inc.
$1,519
Janssen Pharmaceuticals, Inc
$1,426
Otsuka America Pharmaceutical, Inc.
$1,208
ABBVIE INC.
$708
Neurocrine Biosciences, Inc.
$639
Teva Pharmaceuticals USA, Inc.
$515
AbbVie Inc.
$452
Takeda Pharmaceuticals U.S.A., Inc.
$369
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$226
Allergan Inc.
$216
Allergan, Inc.
$206
Sunovion Pharmaceuticals Inc.
$195
Indivior Inc.
$143
Ironshore Pharmaceuticals Inc.
$139
Avanir Pharmaceuticals, Inc.
$126
E.R. Squibb & Sons, L.L.C.
$115
ACADIA Pharmaceuticals Inc
$107
Vanda Pharmaceuticals Inc.
$100
AstraZeneca Pharmaceuticals LP
$83
Lundbeck LLC
$83
ITI, Inc.
$61
Adlon Therapeutics L.P.
$55
Eisai Inc.
$35
Janssen Scientific Affairs, LLC
$27
Shire North American Group Inc
$24
Neuronetics, Inc.
$23
Supernus Pharmaceuticals, Inc.
$12
Top 3 companies account for 47.1% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · ARISTADA · AUSTEDO · Aristada 441 mg · BRINTELLIX · CAPLYTA · COBENFY · Dayvigo · FARXIGA · Fanapt · HETLIOZ · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · LATUDA · LYBALVI · MYDAYIS · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · NUPLAZID · PERSERIS · QELBREE · REXULTI · SPRAVATO · TRINTELLIX · Trintellix · UZEDY · VRAYLAR · VYVANSE · Vyvanse
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for psychiatry in CA.

Looking for a psychiatry specialist in Los Angeles?
Compare psychiatrists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
1,922
Per 100K population
19.5
County median income
$87,760
Nearest hospital
PIH HEALTH GOOD SAMARITAN HOSPITAL
2.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Won is a clinical cardiology specialist, with above-average Medicare volume (top 24% in CA), with low-engagement industry engagement in the top 6% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Won experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Won performed 320 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Won receive payments from pharmaceutical companies?
Yes. Dr. Won received a total of $8,812 from 27 companies across 500 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Won's costs compare to other psychiatrists in Los Angeles?
Dr. Won's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Won) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →